[HTML][HTML] Exploring the therapeutic potential of natural compounds in psoriasis and their inclusion in nanotechnological systems

AF Burlec, M Hăncianu, B Ivănescu, I Macovei… - Antioxidants, 2024 - mdpi.com
Psoriasis is a chronic inflammatory disease that affects around 2–3% of the world's
population. The treatment for this autoimmune disease still remains centered around …

[HTML][HTML] Aquaporin channels in skin physiology and aging pathophysiology: investigating their role in skin function and the hallmarks of aging

N Karimi, V Ahmadi - Biology, 2024 - mdpi.com
This study examines the critical role of aquaporins (AQPs) in skin physiology and aging
pathophysiology. The skin plays a vital role in maintaining homeostasis by acting as a …

[HTML][HTML] Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing Rosa× damascena Mill. Extract

DI Gavra, D Kósa, Á Pető, L Józsa, Z Ujhelyi… - …, 2024 - pmc.ncbi.nlm.nih.gov
Psoriasis is a chronic autoimmune skin condition characterized by red, circumscribed, scaly,
and erythematous plaques that can cover large skin areas. While conventional treatments …

New Insights in Psoriasis Management using Herbal Drug Nanocarriers

SP Salgaonkar, JS Purewal, GM Doshi… - Current …, 2024 - benthamdirect.com
Psoriasis (Pso) is an autoimmune inflammatory skin disease characterized by red plaques
covered in silver scales. The existing treatments provide limited benefits and are associated …

[HTML][HTML] Development of Salvia officinalis–Based Self-Emulsifying Systems for Dermal Application: Antioxidant, Anti-Inflammatory, and Skin Penetration Enhancement

K Bodnár, B Papp, D Sinka, P Fehér, Z Ujhelyi, I Lekli… - Pharmaceutics, 2025 - mdpi.com
Background/Objectives: The present study focused on the formulation and evaluation of
novel topical systems containing Salvia officinalis (sage), emphasizing their antioxidant and …

Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review

A Modarresi Chahardehi, HR Ojaghi… - Frontiers in …, 2024 - frontiersin.org
Psoriasis, a persistent immune-mediated inflammatory skin condition, affects approximately
2-3% of the global population. Current treatments for psoriasis are fraught with limitations …

PAMAM dendrimers as mediators of dermal and transdermal drug delivery: a review

M Kirkby, AHB Sabri, A Holmes… - Journal of Pharmacy …, 2024 - academic.oup.com
Objectives Poly (amidoamine) dendrimers have been widely investigated as potential
nanomaterials that can enhance the skin permeation of topically applied drugs. This article …

A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management

RK Thakur, A Kumar, K Aggarwal, N Sood… - Naunyn-Schmiedeberg's …, 2025 - Springer
Psoriasis, a chronic autoimmune and non-communicable skin disease, affects 2–3% of the
global population, creating a significant financial burden on healthcare systems worldwide …

Psorijaza-patogeneza i liječenje

T Jalšovec - 2024 - repository.biotech.uniri.hr
Psorijaza je kronična upalna bolest kože, karakterizirana abnormalnom proliferacijom
keratinocita u gorenjem sloju kože. Ona je multigenska i imunološki posredovana bolest …